HCPCS Level IImedical_servicesActive
M0250
Adm tocilizu covid-19 2nd
BETOS: O1G
Effective: 2021-06-24
Description
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose
Medicare Fee Schedule
2026 Medicare Physician Fee Schedule national payment rates
Statutory Exclusion
This code has a statutory exclusion from Medicare coverage.